A client with blood type O+ is scheduled for surgery.
The nurse is reviewing the compatibility of blood types for potential transfusion during the procedure.
Which of the following blood types can be safely transfused to this client?

Choice A rationale:

Ensuring that blood products meet quality and safety standards is a fundamental aspect of blood transfusion safety.

Blood products must be properly screened and tested for infectious diseases and compatibility to reduce the risk of adverse reactions in the recipient.

Choice B rationale:

Using the right blood product for the right patient at the right time is a critical safety measure.

Administering the wrong blood type or product can lead to severe and life-threatening reactions, such as hemolytic transfusion reactions.

Choice C rationale:

Applying a barcode system or electronic verification system for patient and product identification is essential for ensuring that the correct blood product is matched to the right patient.

This technology helps prevent administration errors.

Choice D rationale:

Administering blood products using reusable equipment is not recommended due to the risk of cross-contamination and infection transmission.

Single-use, disposable equipment is the standard for blood transfusion to enhance safety.

Choice E rationale:

Disposing of used blood products and materials according to hospital policy is crucial to prevent potential contamination and reduce the risk of infection transmission.

Proper disposal procedures are a part of overall transfusion safety protocols.

Choice D is not a recommended safety measure as using reusable equipment for blood transfusions can increase the risk of contamination and transmission of infections.

Therefore, it should not be included as part of blood transfusion safety measures.

Choice A rationale:

Autologous transfusion involves collecting and storing the patient's blood before a planned surgery or procedure, eliminating the risk of incompatibility, infection, and immunologic reactions associated with allogeneic (donor) blood transfusions.

This option aligns with the patient's religious beliefs and offers a safe alternative.

Choice B rationale:

Erythropoietin therapy stimulates red blood cell production but does not eliminate the need for transfusion entirely.

It may not align with the patient's refusal of blood products due to religious beliefs.

Choice C rationale:

Iron therapy can increase hemoglobin levels but may not completely eliminate the need for transfusion.

It also may not be a suitable alternative for the patient's specific condition.

Choice D rationale:

Hemostatic agents are not a substitute for blood transfusion.

They are used to control bleeding but do not address anemia or increase hemoglobin levels.